BékésM, LangleyDR, CrewsCM. PROTAC targeted protein degraders: the past is prologue. Nature Reviews Drug Discovery, 2022, 21(3):181–200. doi: 10.1038/s41573-021-00371-6.
2.
MullardA. Targeted protein degraders crowd into the clinic. Nature Reviews Drug Discovery, 2021, 20(4):247–250. doi: 10.1038/d41573-021-00052-4.
3.
ArnoldC. PROTAC protein degraders to drug the undruggable enter phase 3 trials. Nature Medicine, 2024, 30(11):3030–3031. doi: 10.1038/d41591-024-00072-8.
